Contacts, documents and full notice history are available with a subscription.
Special Notice NONE Expired 1 notice

Blood Chemistry Analyzer 59th Medical Wing PANDHA-25-P-0000

Solicitation PANDHA-25-P-0000 Copied Notice ID d944e7f7065141608d266a70541b2ca4 Copied DEPT OF DEFENSE — DEFENSE HEALTH AGENCY
SAM.gov
Posted
Mar 05, 2026
Deadline
Mar 20, 2026
Set-aside
NONE
NAICS
325413
PSC
6550

Summary

AI-generated · Mar 09, 2026

Two blood chemistry analyzers must be leased, on a sole-source basis to Werfen (NEO Iris system), to deliver a highly specialized, single-platform test menu including antibody screen, ABO/Rh, antibody titration and identification, syphilis, CMV, HIV/HBV/HCV by NAT, WNV, Babesia, HBsAg, HBcAb, HCV Ab, HIV Ab, HTLV Ab, and Chagas, with capability to test both plasma and whole blood. The system must support a comprehensive, FDA-approved NAT panel on a single automated platform, as only the Werfen NEO Iris integrates these exact assays and interoperability on one unit; other vendors offer tests on multiple platforms, creating space, staffing, and LIS integration challenges, which are incompatible with the mission's high-throughput needs.

The analyzer must fit within the 59th Medical Wing’s lab space without on-site water or floor drainage, occupying no more than 86.6 inches wide by 35.4 inches deep by 73.2 inches high, with self-contained fluidics and waste management. It requires advanced sample handling for pediatric and low-volume samples—clot, bubble, and short-sample detection; automatic reflex dilution and repeat testing; preservation of pediatric samples after aspiration error; and a proprietary dual-arm pipettor with liquid-level sensing and clog detection. Bi-directional, validated interfaces with the facility’s EHR and LIS are required, enabling seamless integration with existing DoD systems and minimal facility modification. This notice indicates a sole-source intent to Werner, with capability statements invited from other parties, though no competitive procurement is planned.

This notice is to advise the public of the intent of Defense Health Agency HCD-S to award a sole source contract to the contractor identified below. WERFEN USA LLC (Werfen) 180 HARTWELL RD BEDFORD MA 01730-2443 Description of Requirement: Defense Health Agency HCD-S has a requirement for two (2) Blood Chemistry Analyzers (lease). Justification for Sole Source Procurement: The nature of this acquisition is highly specialized. The combination of technical specifications, physical constraints, and interoperability requirements creates a unique need that can only be met by one vendor, Werfen , with their NEO Iris system. No other known system can meet all of the Government's minimum requirements as detailed below: Proprietary & Integrated Test Menu: The Government requires a comprehensive and specific panel of tests to be performed on a single platform, including highly specialized Antibody Screen, ABO/Rh, Antibody Titration, Antibody identification, Syphilis, Cytomegalovirus, HIV/HBV/HCV by Nucleic acid testing, WNV, Babesia, Hepatitis B Surface Antigen (HBsAg),Hepatitis B core Antibody (HBcAb), Hepatitis C Antibody (HCV Ab), Human Immunodeficiency virus types 1 and 2 antibody (HIV ab), Human T Lymphotrophic virus types 1 and 2 antibody (HTLV Ab), Chagas. The machine must also be able to test plasma and whole blood. Market research indicates that only the Werden NEO Iris system integrates this exact combination of assays, including the critical, FDA-approved NAT tests, onto a single automated platform. Other vendors offer these tests on separate platforms, which would require additional space, increased staffing, workflow inefficiencies, and present significant integration challenges with our Laboratory Information System (LIS). This single, integrated platform is essential to meet the high-throughput demands of the Basic Military Training mission. Unique Physical and Infrastructure Requirements: The laboratory space at the 59th MDW has strict and unalterable infrastructure limitations. The required analyzer must operate without an onsite water source or a floor drainage system and must not exceed the physical dimensions of 86.6 W x 35.4 D x 73.2 H. The NEO Iris analyzer is specifically designed to operate with self-contained fluidics and waste management, eliminating the need for external plumbing. This design feature, combined with its specific physical footprint, makes it the only system capable of being installed and operated in the designated space without costly and mission-disrupting facility modifications. Advanced Sample Integrity and Handling: The SOW mandates a system with a unique combination of sample handling capabilities critical for the pediatric and low-volume samples common in a military trainee population. This includes clot, bubble, and short sample detection, automatic reflex dilution and repeat testing, and the ability to preserve pediatric samples upon aspiration error. The Werfen NEO Iris system utilizes a proprietary dual-arm pipettor with advanced liquid level sensing and clog detection that is uniquely capable of meeting all these requirements simultaneously, ensuring sample integrity and minimizing the need for painful and time-consuming redraws from trainees. Interoperability with Existing Systems: The analyzer must establish a bi-directional interface with the hospital's Electronic Health Record (EHR) and Laboratory Information System (LIS). The NEO Iris system has a proven and validated interface that is currently operational at other DoD facilities, ensuring seamless integration without extensive and risky custom development. Response and Challenge: Interested parties who believe they can meet the requirements are invited to submit a statement of capabilities and qualifications. This statement must be submitted in writing to the contact person identified in this notice and must be received no later than the noted time and date. The statement of capabilities must include: Company name, address, point of contact, telephone number, and email address. A detailed description of your company's capabilities to provide the specified requirement. Evidence that your company meets all the requirements outlined in the "Description of Requirement" section. Any other information that demonstrates your ability to perform the work. A determination by the Defense Health Agency HCD-S not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the HCD-S. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. This notice of intent is not a request for competitive proposals.

From Special Notice posted on Mar 05, 2026

Notice history

1
  1. Special Notice LATEST Posted Mar 05, 2026 View

Details

Solicitation number PANDHA-25-P-0000
Notice ID d944e7f7065141608d266a70541b2ca4
Notice type Special Notice
Product / Service (PSC) 6550
NAICS 325413
Set-aside No Set aside used
Place of performance DWG, Texas
Archive date Apr 04, 2026

Award Information

Not yet awarded

Documents

No files available

View on SAM.gov

Contacts

primary
Jorge Canavati

Email

secondary
Joe Wells

Email

Agency

DEPT OF DEFENSE
DEFENSE HEALTH AGENCY (DHA)
DEFENSE HEALTH AGENCY

Place of Performance

DWG, Texas 78236
USA

Dates

Posted Mar 05, 2026 5 months ago
Last Updated Aug 06, 2026 2 days ago
Due Mar 20, 2026 4 months ago